Company / Gross Profit per Share
BioLife Solutions, Inc. Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$1.28
FY2025
5-year range
$0.95 / $1.28
FY2021-FY2025
Trend
+17.4%
vs FY2024
Sector context
#89 of 94
Health Care
What the data says
Among 94 Health Care companies, BioLife Solutions, Inc. is in the bottom 5% for gross profit per share. Gross Profit per Share has increased for 5 consecutive years, from $0.38 in FY2016 to $1.28 in FY2025.
Based on SEC 10-K filings.
1.28 in FY2025.
Improved from $0.95 to $1.28 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 94This company $1.28 Sector average $14.29
▼
-91.1% below sector average
Key checks
Key Insights
- In FY2025, gross profit per share increased 17.4% year-over-year.
- Ranks #89 out of 94 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.28 | +17.4% |
| FY2024 | $1.09 | +15.1% |
| FY2023 | $0.95 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0.92 | +76.1% |
| FY2017 | $0.52 | +36.6% |
| FY2016 | $0.38 | +21.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026